Agave inulin supplementation affects the fecal microbiota of healthy adults participating in a randomized, double-blind, placebo-controlled, crossover trial

Journal of Nutrition

Volumn 145, Issue 9, 2015, Pages 2025-2032

  Holscher, Hannah D ^a   Bauer, Laura L ^a   Gourineni, Vishnupriya ^b   Pelkman, Christine L ^b   Fahey, George C ^a   Swanson, Kelly S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b Global Nutrition Ingredion Inc   (United States)

Author keywords

Agave; Bifidobacteria; Butyrate; Fiber; Inulin; Microbiota; Prebiotics

Indexed keywords

AGAVE INULIN; BUTYRIC ACID; INULIN; PLACEBO; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; BACTERIAL DNA; PREBIOTIC AGENT;

ACTINOBACTERIA; ADULT; AGAVE; ARTICLE; BACTERIAL STRAIN; BACTERIUM; BIFIDOBACTERIUM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DESULFOVIBRIO; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES; FECES MICROFLORA; FEMALE; FERMENTATION; HUMAN; INTESTINE FLORA; MALE; MICROBIAL COMMUNITY; NORMAL HUMAN; POPULATION ABUNDANCE; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ANALYSIS; ADMINISTRATION AND DOSAGE; DRUG EFFECTS; GASTROINTESTINAL TRACT; GENETICS; MICROBIOLOGY; MICROFLORA; YOUNG ADULT;

ACTINOBACTERIA; ADULT; AGAVE; BIFIDOBACTERIUM; CROSS-OVER STUDIES; DIETARY FIBER; DIETARY SUPPLEMENTS; DNA, BACTERIAL; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INULIN; MALE; MICROBIOTA; PREBIOTICS; YOUNG ADULT;

EID: 84941065503     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.217331     Document Type: Article

References (84)

1. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, Krakoff J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011;94:58-65.
2. Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014;49:785-98.
3. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, DuGar B, Feldstein AE, Britt EB, Fu X, Chung Y. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63.
4. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012;486:207-14.
5. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci USA 2012;109:594-9.
6. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012;490:55-60.
7. De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One 2013;8: e76993.
8. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010;16:444-53.
9. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 2003;78:920-7.
10. Schulze MB, Liu S, Rimm EB, Manson JE, Willett WC, Hu FB. Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr 2004;80:348-56.
11. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 2003;77:622-9.
12. Wolk A, Manson JE, Stampfer MJ, Colditz GA, Hu FB, Speizer FE, Hennekens CH, Willett WC. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999;281:1998-2004.
13. Kromhout D, Bosschieter E, Coulander CDL. Dietary fibre and 10-year mortality from coronary heart disease, cancer, and all causes. The Zutphen Study. Lancet 1982;2:518-22.
14. Streppel MT, Ocke MC, Boshuizen HC, Kok FJ, Kromhout D. Dietary fiber intake in relation to coronary heart disease and all-cause mortality over 40 y: the Zutphen Study. Am J Clin Nutr 2008;88:1119-25.
15. US Department of Agriculture and US Department of Health and Human Services. Dietary guidelines for Americans. Washington (DC): US Government Printing Office; 2010.
16. King DE, Mainous, III AG, Lambourne CA. Trends in dietary fiber intake in the United States, 1999-2008. J Acad Nutr Diet 2012;112:642-8.
17. Cho SS, Qi L, Fahey GC, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr 2013;98:594-619.
18. Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J Natl Cancer Inst 1990;82:650-61.
19. Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, Jacobs DR, Jr. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999;282:1539-46.
20. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G. Dietary prebiotics: current status and new definition. Food Sci Technol Bull Funct Foods. 2010;7:1-19.
21. Cummings JH. Short chain fatty acids in the human colon. Gut 1981;22:763-79.
22. Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 2012;4:4.
23. Canani RB, Costanzo M, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011;17:1519-28.
24. Chen YX, Fang JY, Lu J, Qiu DK. Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines. Zhonghua Yi Xue Za Zhi 2004;84:312-7.
25. Binder HJ, Mehta P. Short-chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon. Gastroenterology 1989;96:989-96.
26. Comalada M, Bailon E, de Haro O, Lara-Villoslada F, Xaus J, Zarzuelo A, Galvez J. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol 2006;132:487-97.
27. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003;133:2485S-93S.
28. Lührs H, Gerke T, Müller J, Melcher R, Schauber J, Boxberger F, Scheppach W, Menzel T. Butyrate inhibits NF-kB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002;37:458-66.
29. Rabbani GH, Albert MJ, Rahman H, Chowdhury AK. Short-chain fatty acids inhibit fluid and electrolyte loss induced by cholera toxin in proximal colon of rabbit in vivo. Dig Dis Sci 1999;44:1547-53.
30. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994;35:S35-8.
31. Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schröder O. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NFkB signalling. Mol Immunol 2007;44:3625-32.
32. Schaafsma G, Slavin JL. Significance of inulin fructans in the human diet. Compr Rev Food Sci Food Safety. 2015;14:37-47.
33. Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, Hatch T, Sun S, Tappenden KA. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 2012;36 1 Suppl:95S-105S.
34. Brownawell AM, Caers W, Gibson GR, Kendall CW, Lewis KD, Ringel Y, Slavin JL. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr 2012;142:962-74.
35. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006;72:3593-9.
36. Dong P, Yang Y, WangW. The role of intestinal bifidobacteria on immune system development in young rats. Early Hum Dev 2010;86:51-8.
37. López P, González-Rodríguez I, Gueimonde M, Margolles A, Suárez A. Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity. PLoS One 2011;6:e24776.
38. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 2008;74:660-6.
39. Santacruz A, Collado MC, Garcia-Valdés L, Segura MT, Martin-Lagos JA, Anjos T, Marti-Romero M, Lopez RM, Florido J, Campoy C, Sanz Y. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010;104:83-92.
40. Ventura M, Turroni F, Bottacini F, Giubellini V, van Sinderen D. Bifidobacterial ecology and comparative genomics: perspectives. Bifidobacteria Genomics Molbi Aspects 2010:31.
41. Lopez MG, Mancilla-Margalli NA, Mendoza-Diaz G. Molecular structures of fructans from Agave tequilana Weber var. azul. J Agric Food Chem 2003;51:7835-40.
42. Roberfroid MB, Van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998;128:11-9.
43. Allsopp P, Possemiers S, Campbell D, Oyarzábal IS, Gill C, Rowland I. An exploratory study into the putative prebiotic activity of fructans isolated from Agave angustifolia and the associated anticancer activity. Anaerobe 2013;22:38-44.
44. Gomez E, Tuohy K, Gibson G, Klinder A, Costabile A. In vitro evaluation of the fermentation properties and potential prebiotic activity of Agave fructans. J Appl Microbiol 2010;108:2114-21.
45. Márquez-Aguirre AL, Camacho-Ruíz RM, Arriaga-Alba M, Padilla-Camberos E, Kirchmayr MR, Blasco JL, González-Ávila M. Effects of Agave tequilana fructans with different degree of polymerization profiles on body weight, blood lipids and fecal Lactobacilli/Bifidobacteria in obese mice. Food Funct 2013;4:1237-44.
46. Rendón-Huerta JA, Juárez-Flores B, Pinos-Rodríguez JM, Aguirre-Rivera JR, Delgado-Portales RE. Effects of different sources of fructans on body weight, blood metabolites and fecal bacteria in normal and obese nondiabetic and diabetic rats. Plant Foods Hum Nutr 2012;67:64-70.
47. Urías-Silvas JE, Cani PD, Delmée E, Neyrinck A, López MG, Delzenne NM. Physiological effects of dietary fructans extracted from Agave tequilana Gto and Dasylirion spp. Br J Nutr 2008;99:254-61.
48. Holscher HD, Doligale JL, Bauer LL, Gourineni V, Pelkman CL, Fahey GC, Swanson KS. Gastrointestinal tolerance and utilization of agave inulin by healthy adults. Food Funct 2014;5:1142-9.
49. Association of Official Analytical Chemists. Official methods of analysis. Washington (DC): AOAC; 1984.
50. Chaney AL, Marbach EP. Modified reagents for determination of urea and ammonia. Clin Chem 1962;8:130-2.
51. Boler BM, Serao MC, Bauer LL, Staeger MA, Boileau TW, Swanson KS, Fahey GC, Jr. Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr 2011;106:1864-71.
52. Flickinger EA, Schreijen EM, Patil AR, Hussein HS, Grieshop CM, Merchen NR, Fahey GC, Jr. Nutrient digestibilities, microbial populations, and protein catabolites as affected by fructan supplementation of dog diets. J Anim Sci 2003;81:2008-18.
53. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012;6:1621-4.
54. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
55. Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, Mills DA, Caporaso JG. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods 2013;10:57-9.
56. Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J 2011;5:169-72.
57. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 2009;101:541-50.
58. De Vuyst L, Leroy F. Cross-feeding between bifidobacteria and butyrateproducing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 2011;149:73-80.
59. Muramatsu K, Onodera S, Kikuchi M, Shiomi N. Purification and some properties of b-fructofuranosidase from Bifidobacterium adolescentis G1. Biosci Biotechnol Biochem 1993;57:1681-5.
60. Falony G, Verschaeren A, De Bruycker F, De Preter V, Verbeke K, Leroy F, De Vuyst L. In vitro kinetics of prebiotic inulin-type fructan fermentation by butyrate-producing colon bacteria: implementation of online gas chromatography for quantitative analysis of carbon dioxide and hydrogen gas production. Appl Environ Microbiol 2009;75:5884-92.
61. Ryan SM, Fitzgerald GF, van Sinderen D. Transcriptional regulation and characterization of a novel beta-fructofuranosidase-encoding gene from Bifidobacterium breve UCC2003. Appl Environ Microbiol 2005;71:3475-82.
62. Van der Meulen R, Avonts L, De Vuyst L. Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010. Appl Environ Microbiol 2004;70:1923-30.
63. Falony G, Calmeyn T, Leroy F, De Vuyst L. Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. Appl Environ Microbiol 2009;75:2312-9.
64. Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S, Matteuzzi D. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 2005;71:6150-8.
65. Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F, Rambaud JC. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J Nutr 1999;129:113-6.
66. Davis LM, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 2011;6:e25200.
67. Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT. Human genetics shape the gut microbiome. Cell 2014;159:789-99.
68. Levitt MD. Production and excretion of hydrogen gas in man. N Engl J Med 1969;281:122-7.
69. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG, Jr. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980;78:1500-7.
70. Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013;14:685-90.
71. Scanlan PD, Shanahan F, Marchesi JR. Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals. FEMS Microbiol Ecol 2009;69:213-21.
72. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004;229:586-97.
73. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:179-84.
74. Gibson G, Cummings J, Macfarlane G. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Lett 1991;86:103-11.
75. Christl SU, Scheppach W, Kasper H. Hydrogen metabolism in the large intestine-physiology and clinical implications. Z Gastroenterol 1995;33:408-13.
76. Heberling CA, Dhurjati PS, Sasser M. Hypothesis for a systems connectivity model of autism spectrum disorder pathogenesis: Links to gut bacteria, oxidative stress, and intestinal permeability. Med Hypotheses 2013;80:264-70.
77. Alvaro A, Sola R, Rosales R, Ribalta J, Anguera A, Masana L, Vallvé JC. Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life 2008;60:757-64.
78. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009;58:1509-17.
79. Martínez I, Kim J, Duffy PR, Schlegel VL, Walter J. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS One 2010;5:e15046.
80. Hooda S, Boler BMV, Serao MCR, Brulc JM, Staeger MA, Boileau TW, Dowd SE, Fahey GC, Swanson KS. 454 pyrosequencing reveals a shift in fecal microbiota of healthy adult men consuming polydextrose or soluble corn fiber. J Nutr 2012;142:1259-65.
81. Holscher HD, Caporaso JG, Hooda S, Brulc JM, Fahey GC, Jr., Swanson KS. Fiber supplementation influences phylogenetic structure and functional capacity of the human intestinal microbiome: follow-up of a randomized controlled trial. Am J Clin Nutr 2015;101:55-64.
82. Angus F, Smart S, Shortt C. Prebiotic ingredients with emphasis on galactooligosaccharides and fructo-oligosaccharides. In: Tamime AY, editor. Probiotic dairy products. New York: Blackwell Publishing; 2005. P.120-37.
83. Lahtinen SJ, Knoblock K, Drakoularakou A, Jacob M, Stowell J, Gibson GR, Ouwehand AC. Effect of molecule branching and glycosidic linkage on the degradation of polydextrose by gut microbiota. Biosci Biotechnol Biochem 2010;74:2016-21.
84. Knapp BK, Bauer LL, Swanson KS, Tappenden KA, Fahey GC, De Godoy MR. Soluble fiber dextrin and soluble corn fiber supplementation modify indices of health in cecum and colon of Sprague-Dawley rats. Nutrients 2013;5:396-410.